 | | | | NEW YORK (Reuters) - Allergan Inc was sued on Wednesday by four large U.S. retailers that accused the drugmaker of antitrust violations for trying to stop rivals from selling generic versions of Restasis, its medication to treat dry-eye disease. | | |
| | | KINSHASA (Reuters) - Congo Health Minister Oly Ilunga Kalenga late on Wednesday said in a statement that the country's Ebola outbreak had entered "a new phase" after a case of the virus was detected in the northwest city of Mbandaka, with a population of about 1 million people. | | |
| | | (Reuters) - The U.S. Food and Drug Administration on Wednesday approved https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm607884.htm the first non-opioid drug that will help reduce symptoms of opioid withdrawal in adults. | | |
| | | (Reuters) - Roche's immunotherapy Tecentriq, given with its older drug Avastin and chemotherapy, improved survival of advanced lung cancer patients by about 30 percent over the combination without Tecentriq, according to interim results of a late stage trial released on Wednesday. | | |
| | | (Reuters) - The U.S. Food and Drug Administration said on Wednesday the harvest season for romaine lettuce, linked to the multi-state E. coli outbreak, was over and it was unlikely that it was still available in stores due to its 21-day shelf life. | | |
| | | (Reuters) - Treating early stage breast cancer patients for just six months with Roche's Herceptin works as well as the current 12-month regimen, researchers who conducted a large clinical trial said on Wednesday. | | |
| | | (Reuters) - The combination of Merck & Co's immunotherapy Keytruda and chemotherapy boosted response rates in patients with advanced hard-to-treat squamous cell lung cancer, the company said on Wednesday. | | |
| | | FRANKFURT (Reuters) - Germany's Merck KGaA said two of its experimental oncology drugs showed early signs of promise in certain lung cancer patients, potentially helping efforts to find drug-industry partners to share further development costs. | | |
| | | CHICAGO (Reuters) - An experimental Loxo Oncology Inc drug that targets cancers with mistakes in the RET gene led to tumor shrinkage in nearly 70 percent of patients regardless of where their cancer originated, according to preliminary data from a small study released on Wednesday. | | |
| | | GENEVA/KINSHASA (Reuters) - The first batch of 4,000 experimental Ebola vaccines to combat an outbreak suspected of killing 23 people arrived in Congo's capital Kinshasa on Wednesday. | | |
|
| |
